These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6424443)

  • 1. Intravenous immunoglobulin in neonatal group B streptococcal disease. Pharmacokinetic and safety studies in monkeys and humans.
    Fischer GW; Weisman LB; Hemming VG; London WT; Hunter KW; Bosworth JM; Sever JL; Wilson SR; Curfman BL
    Am J Med; 1984 Mar; 76(3A):117-23. PubMed ID: 6424443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
    Fischer GW
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opsonic antibody response of female rats to type III group B streptococcal immunization: a model for maternal immunity.
    Heiman HS; Weisman LE
    Vet Immunol Immunopathol; 1990 Jan; 24(1):79-89. PubMed ID: 2180204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous gamma-globulin in the treatment of neonatal sepsis with special reference to group B streptococci and pharmacokinetics.
    Christensen KK; Christensen P
    Pediatr Infect Dis; 1986; 5(3 Suppl):S189-92. PubMed ID: 3520505
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous administration of human IgG to newborn infants: changes in serum antibody levels to GBS.
    Christensen KK; Christensen P; Seger RA
    Antibiot Chemother (1971); 1985; 35():247-53. PubMed ID: 3901901
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens.
    Hill HR; Augustine NH; Shigeoka AO
    Am J Med; 1984 Mar; 76(3A):61-6. PubMed ID: 6424458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infection.
    Santos JI; Shigeoka AO; Rote NS; Hill HR
    J Pediatr; 1981 Dec; 99(6):873-9. PubMed ID: 7031210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates.
    Weisman LE; Anthony BF; Hemming VG; Fischer GW
    J Pediatr; 1993 Jun; 122(6):929-37. PubMed ID: 8501574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maternal deficiency of IgG 2 and IgG 4 and neonatal infection caused by B-streptococci].
    Maak B; Müller E; Berbig H; Estel C
    Zentralbl Gynakol; 1993; 115(3):136-9. PubMed ID: 8465627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.
    Baker CJ; Rench MA; Edwards MS; Carpenter RJ; Hays BM; Kasper DL
    N Engl J Med; 1988 Nov; 319(18):1180-5. PubMed ID: 3050524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative protective activity of human monoclonal and hyperimmune polyclonal antibody against group B streptococci.
    Hill HR; Gonzales LA; Knappe WA; Fischer GW; Kelsey DK; Raff HV
    J Infect Dis; 1991 Apr; 163(4):792-8. PubMed ID: 2010632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous administration of human IgG to newborn infants: changes in serum antibody levels to group B streptococci.
    Christensen KK; Christensen P; Bucher HU; Duc G; Kind CH; Mieth D; Müller B; Seger RA
    Eur J Pediatr; 1984 Dec; 143(2):123-7. PubMed ID: 6394336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci.
    Fischer GW; Wilson SR; Hunter KW
    J Clin Immunol; 1982 Apr; 2(2 Suppl):31S-35S. PubMed ID: 7045156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
    Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
    Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: a review.
    Fischer GW; Weisman LE; Hemming VG
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S92-7. PubMed ID: 1728993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravenous immunoglobulin (Sandoglobulin) in neonates.
    Weisman LE; Fischer GW; Hemming VG; Peck CC
    Pediatr Infect Dis; 1986; 5(3 Suppl):S185-8. PubMed ID: 3520504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoprecipitation and opsonic cross-reaction between type-14 pneumococcus and group-B streptococcus type III.
    Fischer GW; Lowell GH; Crumrine MH; Wilson SR
    Lancet; 1979 Jan; 1(8107):75-7. PubMed ID: 84130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.
    Baker CJ; Kasper DL
    N Engl J Med; 1976 Apr; 294(14):753-6. PubMed ID: 768760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin therapy for neonatal sepsis: an overview of animal and clinical studies.
    Fischer GW
    J Clin Immunol; 1990 Nov; 10(6 Suppl):40S-46S. PubMed ID: 2081788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal cellular and humoral immunity to group B streptococci.
    Hill HR; Shigeoka AO; Hall RT; Hemming VG
    Pediatrics; 1979 Nov; 64(5 Pt 2 Suppl):787-94. PubMed ID: 388335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.